Atherothrombotic Disease
Main Article Content
Abstract
Clinical manifestations of atherothrombotic disease, cardiac arrhythmia and myocardial infarction account for the most common causes of sudden, unexpected death in all age groups.1 A multicenter study of cardiac death in Thailand showed that of the NSTEMI 2653 cases, cardiac death were 202 cases (7.6%).2
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This article is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). You may copy and redistribute the material for noncommercial purposes, provided that appropriate credit is given and a link to the license is included. Modified versions may not be distributed under this license.
License: https://creativecommons.org/licenses/by-nc-nd/4.0/
References
2. Hutayanon P, Sarakan P, Buakhamsri A, et al. The effect of the public or private Status of health care Facility in Acute coronary syndrome: data from Thai ASC registry. J Med Assoc Thai 2007;90:97-107.
3. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction. N Engl J Med 2006;345:1477-88.
4. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non-Q-Wave Myocardial Infarction Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B Trial. Circulation 1999;100:1593-601.
5. Hassink RJ, Haerkens-Arends HE and Daniels MC. Extensive right coronary artery thrombosis. Neth Heart J 2009;17:115-6.
6. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of “No flow” after percutaneous coronary intervention. Circul 1994;89:2514-8.
7. Weitz IJ. Low molecular-weight heparins. N Engl J Med 1997;337:688-99.